Skip to content
Study details
Enrolling now

Autoimmune Intervention Mastery Course Study

Terry L. Wahls
NCT IDNCT05057676ClinicalTrials.gov data as of Apr 2026
Target enrollment

400

Study length

about 6 years

Ages

18–100

Locations

1 site in IA

About this study

Researchers are testing if an online program helps people with MS, CIS, fibromyalgia, post-COVID conditions, and cancer in remission improve their diet and self-care. The trial will compare different ways of delivering the program: delayed question and answer sessions, a delayed course, immediate questions and answers, or an immediate course.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Delayed AIM Question and Answer sessions
  • 2.Participate in Delayed Autoimmune Intervention Mastery Course (delayed AIM course)
  • 3.Participate in Immediate Autoimmune Intervention Mastery Course (AIM)
  • +1 more
Primary goalMultiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH)

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low3%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH), Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH), Short form 36 (SF 36), The Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-FS):

Secondary: Brief Pain Inventory, Modified Fatigue Impact Scale, Pain catastrophizing scale, Pain scale

Body systems

Oncology, Neurology, Musculoskeletal, Infectious